Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Clinical trial NCT05077969 · TERMINATED

Trial details

NCT number: NCT05077969
Sponsor: Leidos Life Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

2019 Novel Coronavirus Disease 2019 Novel Coronavirus Infection 2019-nCoV Disease 2019-nCoV Infection COVID-19 COVID-19 Pandemic COVID-19 Virus Disease COVID-19 Virus Infection Covid19 Coronavirus Disease 2019 SARS-CoV2 Infection SARS-CoV-2 Acute Respiratory Disease

Start date: 2021-12-29
Primary completion: 2022-06-28
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.